Show simple item record

dc.contributor.authorCampbell, Zoe
dc.contributor.authorMwangi, Thumbi
dc.contributor.authorMarsh, Thomas
dc.contributor.authorQuinlan, Marsha
dc.contributor.authorShirima, Gabriel
dc.contributor.authorPalmer, Guy
dc.date.accessioned2020-03-27T07:04:50Z
dc.date.available2020-03-27T07:04:50Z
dc.date.issued2019-08-15
dc.identifier.urihttps://doi.org/10.1371/journal.pone.0220963
dc.identifier.urihttps://dspace.nm-aist.ac.tz/handle/20.500.12479/671
dc.descriptionThis research article published by PLOS ONE, 2019en_US
dc.description.abstractUnderstanding preferences for veterinary vaccines in low and middle-income countries is important for increasing vaccination coverage against infectious diseases, especially when the consumer is responsible for choosing between similar vaccines. Over-the-counter sales of vaccines without a prescription gives decision-making power to consumers who may value vaccine traits differently from national or international experts and vaccine producers and distributers. We examine consumer preferences for La Sota and I-2 Newcastle disease vaccines in Tanzania to understand why two vaccines co-exist in the market when I-2 is considered technically superior because of its thermotolerance. Household survey and focus group results indicate consumers perceive both vaccines to be effective, use the two vaccines interchangeably when the preferred vaccine is unavailable, and base preferences more on administration style than thermotolerance. Considering the consumers’ perspectives provides a way to increase vaccination coverage by targeting users with a vaccine that fits their preferences.en_US
dc.language.isoenen_US
dc.publisherPLOS ONEen_US
dc.subjectResearch Subject Categories::NATURAL SCIENCESen_US
dc.titleWhy isn’t everyone using the thermotolerant vaccine? Preferences for Newcastle disease vaccines by chicken-owning households in Tanzaniaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record